UB Paderborn / Katalog / Suche / in CDI

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

The lancet oncology, 2011-10, Vol.12 (11), p.1013-1022

2011

Volltextzugriff (PDF)

Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma

Bone marrow transplantation (Basingstoke), 1999-03, Vol.23 (5), p.413-419

1999

Volltextzugriff (PDF)

CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up

The New England journal of medicine, 2024-02, Vol.390 (8), p.687-700

2024

Volltextzugriff (PDF)

Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected

Journal of clinical pathology, 2009-10, Vol.62 (10), p.948-950

2009

Volltextzugriff (PDF)

POS0030 SAFETY AND PRELIMINARY EFFICACY OF CD19 CAR-T CELL TREATMENT IN RHEUMATIC DISEASE- DATA FROM THE FIRST PART OF THE PHASE I/II CASTLE BASKET STUDY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.327-327

2024

Volltextzugriff (PDF)

Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute

Neoplasma, 2000, Vol.47 (2), p.129

2000

Volltextzugriff (PDF)

New approaches to management of multiple myeloma

Acta medica Austriaca, 1996, Vol.23 (3), p.91-98

1996

Volltextzugriff (PDF)

Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma

Neoplasma, 2006, Vol.53 (2), p.174

2006

Volltextzugriff (PDF)

Echocardiographic evaluation of early and chronic cardiotoxicity in adult patients treated for Hodgkin's disease with ABVD regimen

Neoplasma, 2006, Vol.53 (1), p.62

2006

Volltextzugriff (PDF)

Evaluation of Acute and Early Cardiotoxicity in Survivors of Hodgkin's Disease Treated with ABVD or BEACOPP Regimens

Journal of chemotherapy (Florence), 2006-04, Vol.18 (2), p.199-208

2006

Volltextzugriff (PDF)

Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantation

Acta medica Austriaca, 1996, Vol.23 (3), p.85

1996

Volltextzugriff (PDF)

Chronic fatigue syndrome in cancer patients. Diagnostic and treatment options

Vnitřní lékar̆stvĭ, 2007-09, Vol.53 (9), p.979-985

2007

Volltextzugriff (PDF)

Herpes simplex infection as possible etiology for febrile neutropenia and mucositis in patients treated for hematological malignancies

Acta medica Austriaca, 1998, Vol.25 (2), p.57-60

1998

Volltextzugriff (PDF)

Staging of non-Hodgkin's lymphoma--recommendations of the Czech Lymphoma Study Group

Klinická onkologie, 2010, Vol.23 (3), p.146-154

2010

Volltextzugriff (PDF)

Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma

International journal of oncology, 2010-03, Vol.36 (3), p.699-706

2010

Volltextzugriff (PDF)

Comparison of plasmatic levels of B-natriuretic peptide with echocardiographic indicators of left ventricle function after doxorubicin therapy

Vnitřní lékar̆stvĭ, 2006-06, Vol.52 (6), p.563

2006

Volltextzugriff (PDF)

Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy

Vnitřní lékar̆stvĭ, 2006-04, Vol.52 (4), p.328

2006

Volltextzugriff (PDF)

Practical aspects and clinical value of t(14;18) monitoring in peripheral blood of the follicular lymphoma patients

Časopis lékařů českých, 2007, Vol.146 (4), p.374-81; discussion 381-2

2007

Volltextzugriff (PDF)

Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy

Vnitřní lékar̆stvĭ, 2006-03, Vol.52 (3), p.221

2006

Volltextzugriff (PDF)

Biological effects of allogenic leukocytes and leukocyte-depleted blood cell products

Vnitřní lékar̆stvĭ, 1995-10, Vol.41 (10), p.713

1995

Volltextzugriff (PDF)

Evaluation of the clinical effectivity and toxicity of the FDN regimen (fludarabin, mitoxantron, dexamethason) in patients with follicular lymphoma

Časopis lékařů českých, 2004, Vol.143 (10), p.685

2004

Volltextzugriff (PDF)

Dexrazoxane in patients with B-lymphomas or acute leukemias in the 2nd complete remission enables further therapy with cardiotoxic anthracyclines over recommended cumulative doses

Vnitřní lékar̆stvĭ, 2004-06, Vol.50 (6), p.438

2004

Volltextzugriff (PDF)

Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma

European journal of haematology. Supplementum, 2001-07, Vol.64, p.21

2001

Volltextzugriff (PDF)

Damage of left ventricular function after treatment with doxorubicin in patients with malignant lymphomas

Vnitřní lékar̆stvĭ, 2000-11, Vol.46 (11), p.768

2000

Volltextzugriff (PDF)

Cardiotoxicity of antineoplastic therapy

Vnitřní lékar̆stvĭ, 2000-03, Vol.46 (3), p.178

2000

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

Ifosfamide and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma

CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up

Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected

POS0030 SAFETY AND PRELIMINARY EFFICACY OF CD19 CAR-T CELL TREATMENT IN RHEUMATIC DISEASE- DATA FROM THE FIRST PART OF THE PHASE I/II CASTLE BASKET STUDY

Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute

New approaches to management of multiple myeloma

Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma

Echocardiographic evaluation of early and chronic cardiotoxicity in adult patients treated for Hodgkin's disease with ABVD regimen

Evaluation of Acute and Early Cardiotoxicity in Survivors of Hodgkin's Disease Treated with ABVD or BEACOPP Regimens

Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantation

Chronic fatigue syndrome in cancer patients. Diagnostic and treatment options

Herpes simplex infection as possible etiology for febrile neutropenia and mucositis in patients treated for hematological malignancies

Staging of non-Hodgkin's lymphoma--recommendations of the Czech Lymphoma Study Group

Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma

Comparison of plasmatic levels of B-natriuretic peptide with echocardiographic indicators of left ventricle function after doxorubicin therapy

Late cardiotoxicity in patients with malignant lymphoma treated with doxorubicin chemotherapy

Practical aspects and clinical value of t(14;18) monitoring in peripheral blood of the follicular lymphoma patients

Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy

Biological effects of allogenic leukocytes and leukocyte-depleted blood cell products

Evaluation of the clinical effectivity and toxicity of the FDN regimen (fludarabin, mitoxantron, dexamethason) in patients with follicular lymphoma

Dexrazoxane in patients with B-lymphomas or acute leukemias in the 2nd complete remission enables further therapy with cardiotoxic anthracyclines over recommended cumulative doses

Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma

Damage of left ventricular function after treatment with doxorubicin in patients with malignant lymphomas

Cardiotoxicity of antineoplastic therapy

Suchergebnisse filtern